2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide

mitogen-activated protein kinase kinase 2 ; Homo sapiens







2 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 16009947 Phase I and pharmacodynamic study of the oral MEK inhibitor CI-1040 in patients with advanced malignancies. 2005 Aug 10 1
2 14613031 CI-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK). 2003 Oct 2